Safety of Parkinson's Drug Nuplazid (Pimavanserin) Being Reviewed by FDA

The safety of the Parkinson’s disease drug Nuplazid is being reviewed by the U.S. Food and Drug Administration.
The drug has been cited as a “suspect” medication in hundreds of deaths reported by health care providers, CNN reported.
Nuplazid,…
Source: Topamax